findmyKOL

Samuel Ellias, MD

Basic profile

Boston University

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyNeurologyFocusNeurology
Last active 2016findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2016Online presenceNot yet checkedPaymentsNone reportedNIH funding1985–1988Why? →

Samuel Ellias is a Neurology physician affiliated with Boston University. OpenAlex indexes 14 publications with 956 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

956citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1985–1988

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

725 Albany St
Shapiro 7, Suite B
Boston, MA 021182526

Telephone

617-638-8456

Registry record last updated 16 Jul 2014.

View the NPPES registry record

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    90.7%
    Aromatic Amino Acid Decarboxylation Inhibitor38%
    Carbidopa-Levodopa72%Carbidopa-Levodopa Er12%Carbidopa-Levodopa-Entacapone7%Rytary6%Carbidopa3%
    Part D<11 patients
    Nonergot Dopamine Agonist8.6%
    Ropinirole Er38%Ropinirole Hcl37%Pramipexole Dihydrochloride26%
    Part D<11 patients

    + 13 more classes in this area

  • Cardiovascular

    6.9%
    Beta blocker4.9%
    Propranolol Hcl Er100%
    Part D11 patients
    alpha-Adrenergic Agonist2%
    Midodrine Hcl100%
    Part D<11 patients
  • Hormonal (systemic)

    2.4%
    Mineralocorticoids2.4%
    Fludrocortisone Acetate100%
    Part D<11 patients
Where care is delivered (Part B)32.7% facility · 67.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19851988 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”